Stocktoria
Pyxis Oncology, Inc. PYXS
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-10-08
Pyxis Oncology, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 2,785,895 | $9.2M | 4.44% |
| RENAISSANCE TECHNOLOGIES LLC | 888,680 | $1.3M | 1.42% |
| MILLENNIUM MANAGEMENT LLC | 397,625 | $580,533 | 0.63% |
| CITADEL ADVISORS LLC | 128,349 | $187,390 | 0.2% |
| TWO SIGMA INVESTMENTS, LP | 73,300 | $107,018 | 0.12% |
| Point72 Asset Management, L.P. | 32,006 | $46,729 | 0.05% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.